About Contraline
Contraline is a company based in Charlottesville (United States) founded in 2015 by Kevin Eisenfrats. It operates as a HealthTech. Contraline has raised $18.62 million across 11 funding rounds from investors including HHS, Afton Scientific and Google Ventures. The company has 7 employees as of December 31, 2021. Contraline offers products and services including ADAM™. Contraline operates in a competitive market with competitors including Kerecis, Kitotech Medical, microMend, Alafair Biosciences and PolyNovo, among others.
- Headquarter Charlottesville, United States
- Employees 7 as on 31 Dec, 2021
- Founders Kevin Eisenfrats
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Contraline, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.62 M (USD)
in 11 rounds
-
Latest Funding Round
$291.44 K (USD), Grant
Sep 10, 2024
-
Investors
HHS
& 16 more
-
Employee Count
7
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Contraline
Contraline offers a comprehensive portfolio of products and services, including ADAM™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
An implant is developed for long-lasting male contraception.
Unlock access to complete
Unlock access to complete
Funding Insights of Contraline
Contraline has successfully raised a total of $18.62M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $291.44 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $291,440
- First Round First Round
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Contraline | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - Contraline | Valuation | Google Ventures | |
| Oct, 2021 | Amount | Series A - Contraline | Valuation | MBX Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Contraline
Contraline has secured backing from 17 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Afton Scientific and Google Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments are focused on reproductive healthcare startups by Rhia Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Contraline
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Contraline
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Contraline Comparisons
Competitors of Contraline
Contraline operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kitotech Medical, microMend, Alafair Biosciences and PolyNovo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Developer of a device to close wounds, lacerations, and surgical incisions
|
|
| domain | founded_year | HQ Location |
Solutions for treating dermatological disorders are provided by microMend.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Developer of biodegradable temporising matrix for treating traumatic wounds
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Contraline
Frequently Asked Questions about Contraline
When was Contraline founded?
Contraline was founded in 2015.
Where is Contraline located?
Contraline is headquartered in Charlottesville, United States. It is registered at Charlottesville, Virginia, United States.
Who is the current CEO of Contraline?
Kevin Eisenfrats is the current CEO of Contraline. They have also founded this company.
Is Contraline a funded company?
Contraline is a funded company, having raised a total of $18.62M across 11 funding rounds to date. The company's 1st funding round was a Series A of $10.7M, raised on Jun 01, 2015.
How many employees does Contraline have?
As of Dec 31, 2021, the latest employee count at Contraline is 7.
What does Contraline do?
Contraline is engaged in the development of male contraception technologies. The company is based in the healthcare sector, specifically targeting medical devices for contraception. Their flagship product, ADAM, is designed as the worlds first implant for long-lasting and reversible male contraception, comparable to an IUD for men. Clinical trials for this investigational device have been initiated, marking a significant advancement in male contraceptive options since the vasectomy.
Who are the top competitors of Contraline?
Contraline's top competitors include Kerecis, Kitotech Medical and Alafair Biosciences.
What products or services does Contraline offer?
Contraline offers ADAM™.
Who are Contraline's investors?
Contraline has 17 investors. Key investors include HHS, Afton Scientific, Google Ventures, Rhia Ventures, and ShangBay Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.